ArticleBMC neurology2022
Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosis.
Robert J Fox et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it